MMC is a venture capital firm that invests growth capital in UK companies. As an active investor they look to work closely and in partnership with impressive management teams. Their focus on growth leads investment particularly in healthcare, financial services, support services and technology.
They have substantial capital available through managed funds and a syndicate of private investors. Since MMC began investing in 2000 it has established a strong track record of growing and selling businesses. MMC was named EIS Fund Manager of the Year by the EISA in January 2009. MMC first invested in Neoss in 2003.
Delta Partners is a venture capital firm investing in Ireland and the United Kingdom. It was established in 1994 and has €230 million under management. The firm has a strong focus on investing in early stage technology companies, and the team has made over 50 investments in information technology, communications and healthcare.
Delta Partners is among the most active early stage investors in Europe. The partners’ backgrounds in operations, strategy and finance complement the drive and ambition of entrepreneurial management teams. Delta Partners first invested in Neoss in 2003.
In 2006 Medtronic, the $11.3 billion US based medical device company and a world leader in medical technology, invested in Neoss.
Medtronic’s partnership with Neoss gives us access to leading edge technology and provides us with a platform for research and scientific development which is unique in the industry today.
Souter Investments is the private investment office of Stagecoach founder Brian Souter. Our portfolio contains 120 investments with a value in excess of £400 million. The simplicity of the Neoss implant technology is its competitive advantage, and the enormous potential growth in the US market and cosmetic dentistry around the world attracted Souter Investments to invest in 2010.